Nu Skin Enterprises Inc.
NUS evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for NUS—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Financial data as of Mar 31, 2026.
Run Nu Skin Enterprises Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Nu Skin Enterprises Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
227.4 months
D/E 0.73
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 3 sells (180d)
Runway
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
177
Total value held
$253.6M
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 4,291,263 | $31.2M |
| vanguard capital management llc | 4,126,700 | $30.0M |
| charles schwab investment management inc | 2,143,294 | $15.6M |
| american century companies inc | 2,021,202 | $14.7M |
| dimensional fund advisors lp | 1,735,182 | $12.6M |
| vanguard portfolio management llc | 1,709,553 | $12.4M |
| renaissance technologies llc | 1,700,496 | $12.4M |
| aqr capital management llc | 1,236,338 | $8.9M |
| geode capital management, llc | 1,188,166 | $8.7M |
| state street corp | 1,033,708 | $7.5M |
Showing top 10 of 177 institutional holders of Nu Skin Enterprises Inc.. Open the full 13F history after sign-in.
Short Interest
as of May 20, 2026- % of float
- 5.6%
- Days to cover
- 6.7
- Shares short
- 2,666,934
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
NUS short interestGovernance
Frequently asked questions
Who is the CEO of Nu Skin Enterprises Inc.?
Mr. Ryan S. Napierski is the chief executive officer of Nu Skin Enterprises Inc. (NUS).
Where is Nu Skin Enterprises Inc. headquartered?
Nu Skin Enterprises Inc. (NUS) is headquartered in Provo, UT, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.